652 related articles for article (PubMed ID: 20100815)
21. Active site substitution A82W improves the regioselectivity of steroid hydroxylation by cytochrome P450 BM3 mutants as rationalized by spin relaxation nuclear magnetic resonance studies.
Rea V; Kolkman AJ; Vottero E; Stronks EJ; Ampt KA; Honing M; Vermeulen NP; Wijmenga SS; Commandeur JN
Biochemistry; 2012 Jan; 51(3):750-60. PubMed ID: 22208729
[TBL] [Abstract][Full Text] [Related]
22. P450(BM3) (CYP102A1): connecting the dots.
Whitehouse CJ; Bell SG; Wong LL
Chem Soc Rev; 2012 Feb; 41(3):1218-60. PubMed ID: 22008827
[TBL] [Abstract][Full Text] [Related]
23. Oxidation of indole by cytochrome P450 enzymes.
Gillam EM; Notley LM; Cai H; De Voss JJ; Guengerich FP
Biochemistry; 2000 Nov; 39(45):13817-24. PubMed ID: 11076521
[TBL] [Abstract][Full Text] [Related]
24. Glutamate-haem ester bond formation is disfavoured in flavocytochrome P450 BM3: characterization of glutamate substitution mutants at the haem site of P450 BM3.
Girvan HM; Levy CW; Williams P; Fisher K; Cheesman MR; Rigby SE; Leys D; Munro AW
Biochem J; 2010 Apr; 427(3):455-66. PubMed ID: 20180779
[TBL] [Abstract][Full Text] [Related]
25. Surface display of heme- and diflavin-containing cytochrome P450 BM3 in Escherichia coli: a whole cell biocatalyst for oxidation.
Yim SK; Kim DH; Jung HC; Pan JG; Kang HS; Ahn T; Yun CH
J Microbiol Biotechnol; 2010 Apr; 20(4):712-7. PubMed ID: 20467243
[TBL] [Abstract][Full Text] [Related]
26. An efficient route to selective bio-oxidation catalysts: an iterative approach comprising modeling, diversification, and screening, based on CYP102A1.
Seifert A; Antonovici M; Hauer B; Pleiss J
Chembiochem; 2011 Jun; 12(9):1346-51. PubMed ID: 21591046
[TBL] [Abstract][Full Text] [Related]
27. Role of residue 87 in substrate selectivity and regioselectivity of drug-metabolizing cytochrome P450 CYP102A1 M11.
Vottero E; Rea V; Lastdrager J; Honing M; Vermeulen NP; Commandeur JN
J Biol Inorg Chem; 2011 Aug; 16(6):899-912. PubMed ID: 21567268
[TBL] [Abstract][Full Text] [Related]
28. Crystallographic insights into a cobalt (III) sepulchrate based alternative cofactor system of P450 BM3 monooxygenase.
Panneerselvam S; Shehzad A; Mueller-Dieckmann J; Wilmanns M; Bocola M; Davari MD; Schwaneberg U
Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):134-140. PubMed ID: 28739446
[TBL] [Abstract][Full Text] [Related]
29. Stereoselective hydroxylation of isophorone by variants of the cytochromes P450 CYP102A1 and CYP101A1.
Dezvarei S; Lee JHZ; Bell SG
Enzyme Microb Technol; 2018 Apr; 111():29-37. PubMed ID: 29421034
[TBL] [Abstract][Full Text] [Related]
30. Regioselective hydroxylation of omeprazole enantiomers by bacterial CYP102A1 mutants.
Ryu SH; Park BY; Kim SY; Park SH; Jung HJ; Park M; Park KD; Ahn T; Kang HS; Yun CH
Drug Metab Dispos; 2014 Sep; 42(9):1493-7. PubMed ID: 25008345
[TBL] [Abstract][Full Text] [Related]
31. Co-expression of P450 BM3 and glucose dehydrogenase by recombinant Escherichia coli and its application in an NADPH-dependent indigo production system.
Lu Y; Mei L
J Ind Microbiol Biotechnol; 2007 Mar; 34(3):247-53. PubMed ID: 17171348
[TBL] [Abstract][Full Text] [Related]
32. Regioselective hydroxylation of 17β-estradiol by mutants of CYP102A1 from Bacillus megaterium.
Cha GS; Ryu SH; Ahn T; Yun CH
Biotechnol Lett; 2014 Dec; 36(12):2501-6. PubMed ID: 25129047
[TBL] [Abstract][Full Text] [Related]
33. Application of drug metabolising mutants of cytochrome P450 BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolites.
Damsten MC; van Vugt-Lussenburg BM; Zeldenthuis T; de Vlieger JS; Commandeur JN; Vermeulen NP
Chem Biol Interact; 2008 Jan; 171(1):96-107. PubMed ID: 17996858
[TBL] [Abstract][Full Text] [Related]
34. Control of the stereo-selectivity of styrene epoxidation by cytochrome P450 BM3 using structure-based mutagenesis.
Huang WC; Cullis PM; Raven EL; Roberts GC
Metallomics; 2011 Apr; 3(4):410-6. PubMed ID: 21240430
[TBL] [Abstract][Full Text] [Related]
35. Production of hydroxlated flavonoids with cytochrome P450 BM3 variant F87V and their antioxidative activities.
Kitamura E; Otomatsu T; Maeda C; Aoki Y; Ota C; Misawa N; Shindo K
Biosci Biotechnol Biochem; 2013; 77(6):1340-3. PubMed ID: 23748780
[TBL] [Abstract][Full Text] [Related]
36. Chimeric cytochromes P450 engineered by domain swapping and random mutagenesis for producing human metabolites of drugs.
Kang JY; Ryu SH; Park SH; Cha GS; Kim DH; Kim KH; Hong AW; Ahn T; Pan JG; Joung YH; Kang HS; Yun CH
Biotechnol Bioeng; 2014 Jul; 111(7):1313-22. PubMed ID: 24474032
[TBL] [Abstract][Full Text] [Related]
37. Scanning chimeragenesis: the approach used to change the substrate selectivity of fatty acid monooxygenase CYP102A1 to that of terpene omega-hydroxylase CYP4C7.
Chen CK; Berry RE; Shokhireva TKh; Murataliev MB; Zhang H; Walker FA
J Biol Inorg Chem; 2010 Feb; 15(2):159-74. PubMed ID: 19727859
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of chaperones GroEL/ES from Escherichia coli enhances indigo biotransformation production of cytochrome P450 BM3 mutant.
Peng S; Chu Z; Lu J; Li D; Wang Y; Yang S; Zhang Y
Biotechnol Lett; 2023 Aug; 45(8):993-1000. PubMed ID: 37243776
[TBL] [Abstract][Full Text] [Related]
39. An Enzymatic Route to α-Tocopherol Synthons: Aromatic Hydroxylation of Pseudocumene and Mesitylene with P450 BM3.
Dennig A; Weingartner AM; Kardashliev T; Müller CA; Tassano E; Schürmann M; Ruff AJ; Schwaneberg U
Chemistry; 2017 Dec; 23(71):17981-17991. PubMed ID: 28990705
[TBL] [Abstract][Full Text] [Related]
40. Regioselectivity-driven evolution of CYP102D1 for improved synthesis of 3'-ortho-dihydroxyisoflavone.
Choi KY; Yang YH; Kim BG
Enzyme Microb Technol; 2015 Apr; 71():20-7. PubMed ID: 25765306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
